The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Amgen Inc.

Amgen Inc.
Nasdaq: AMGN
Change
symbol:
     
 NEWS FROM THE WIRES
VW Mexico unit's striking workers to lower wage demand
Aug 22 2001 10:47 AM PDT

US FDA panel backs Amgen arthritis drug Kineret
Aug 16 2001 11:22 AM PDT

US FDA panel backs Amgen arthritis drug Kineret
Aug 16 2001 11:22 AM PDT

Funds: Fund investors eye biotech
Aug 16 2001 09:33 AM PDT

Funds: Fund investors eye biotech
Aug 16 2001 09:33 AM PDT

More WIRE STORIES about this company

 NEWS FROM THE STANDARD
A Cold Call
Jun 12 2001 09:02 AM PDT

Dell Drizzles on Nasdaq's Parade
Jan 22 2001 02:24 PM PST

Mutual Enemy
Jan 16 2001 12:00 AM PST

Out of the Koop
Aug 30 2000 09:10 AM PDT

Twenty-Four More Business Plan Competitions
May 29 2000 12:00 AM PDT

 PROFILE
The biggest of the biotech big'uns, Amgen makes and markets therapeutic products for nephrology, cancer, inflammatory disorders, and metabolic and neurodegenerative diseases. Anti-anemia drug Epogen and immune system stimulator Neupogen account for nearly 90% of sales. Its Infergen has been commercialized as a treatment for hepatitis C, and Stemgen is approved for stem cell therapy in Australia, Canada, and New Zealand. The company has a pipeline of promising drugs in various stages of development. Amgen has research and marketing alliances with several companies, including Hoffmann-La Roche, Johnson & Johnson, and Kirin, the Japanese brewer that also operates a fast-growing pharmaceuticals unit.

 COMPETITION
Abbott Laboratories (ABT)
Johnson & Johnson (JNJ)
Novartis AG (NVS)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 3,448.40
1-Yr. Sales Growth: 7.6%
Employees: 7,300
Revenue per employee: $472,383.56

 KEY PEOPLE
• Kevin W. Sharer
    CEO
• Richard D. Nanula
    CFO

 CONTACT INFO
1 Amgen Center Dr.
Thousand Oaks, CA 91320
US
Phone: 805-447-1000
Fax: 805-447-1010
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001